Search
Renal Cell Carcinoma Research Sheds New Light on Advanced Disease
In a recent study, UCSF researchers found that renal cell carcinoma (RCC)with venous tumor thrombus(VTT) does not always signify metastatic disease with poor prognosis. These findings provide insight into the development of advanced RCC and may help to better inform surveillance regimens and treatment decisions and, ultimately, improve clinical outcomes.Navigating the Maze of Breast Cancer Guidelines: Efficient Paths to Personalized Screening
To help PCPs address patients’ breast cancer screening concerns, surgeon Shoko Emily Abe, MD, FACS, breaks down the multitude of screening directives and modalities, with a focus on the needs of those at average risk and those with dense breast tissue.How Technology, Human Values and New Scrutiny of Old Methods Are Improving Cancer Outcomes
Three surgical oncologists offer exciting news on hepatobiliary, thyroid and breast cancers. First up is a look at benefits of minimally invasive robotic surgery for rectal cancers; regional therapy for metastatic GI cancer; 3D virtual surgical planning; and biomarkers for pancreatic cysts.UCSF Researchers Help Gain FDA Approval for Prostate Cancer Imaging Technique
Method is a ‘game changer’ that should become the standard of care, say UCSF researchers who validated its effectiveness.An Extraordinary Response: A Young Woman’s Path to Overcoming Metastatic Colon Cancer
28-year-old woman mother of two was healthy up until a month prior, when she developed severe anemia, diarrhea and emesis, accompanied by a 25-pound weight loss.Melanoma and Skin Cancer Program
Highly specialized care for patients with melanoma, Merkel Cell and other skin cancersHead and Neck Surgical Oncology
Expert care to improve both survival and quality of lifeAbortion Ban May Increase Risk of Death for Pregnant Women with Cancer
The repercussions of overturning Roe v. Wade – and the failure of the Supreme Court to provide any guidance on exceptions related to the life and health of the mother – are potentially catastrophic for a subset of women who face a life-threating diagnosis of pregnancy associated cancers (PAC).UCSF Cancer Researcher Thomas Martin Receives $4.6 million CIRM Grant
UC San Francisco’s Thomas G. Martin, MD, a leading expert in blood cancers, has received a grant of nearly $4.6 million from the California Institute of Regenerative Medicine (CIRM) to produce a CAR T cell therapy for multiple myeloma, the second most common malignancy among blood cancers.Salivary Gland Transfer for Head & Neck Cancer Patients
Discover the surprising way a simple surgery can vastly improve quality of life for head and neck cancer patients after radiation treatment. How? By moving the submandibular gland out of the way of the most intense radiation to prevent xerostomia.Cancer Update: Safe Opioid Use and Innovations in Blood Cancer Therapies
In this three-part presentation, UCSF substance use experts offer prescribing strategies and tips on patient communication to ensure pain relief without enabling drug dependence.